Paul,
We all make mistakes, nobody is perfect! This forum is to descuse and present our own opinion. I will suggest to all of as:"Read carefuly any press releases, 10Q or 8K reports, prospectus, and recommendations"
After PR announcements for Gladstone collaboration, I read it few times, than go back on last 10Q, and conclud that this is something new for CNSI. If I am wrong, readers of this tread please correct me!
Additionaly to Cerestat and CNS 5161, in I-C Blocker program, CNSI has collaboration with the Epilepsy Branch at NIH for development sodium I-C B, targeting epilepsy.
The latest press shows that CNSI is expanding its research program, which is very important and positive for biotechnology company. Only company with excelent scientific personnel can progress quickly as CNSI did in last years. For me, it is a clear indication that CNSI will grow. Will their stock price folow this? I hope it will!
Concerning sec. PO , I agree with your broker!
Miljenko
|
